Effect of Genetic Polymorphisms of ABCB1, ABCG2, and SLC22A1 on the Steady-State Plasma Concentrations of Lamotrigine in Treatment-Resistant Depressed Patients Treated With Lamotrigine Augmentation Therapy.
Yoko TomoriTakeshi SuzukiKazuo MiharaGoyo NagaiShoko KagawaAkifumi NakamuraKenji NemotoTsuyoshi KondoPublished in: Clinical neuropharmacology (2024)
The present study suggests that these genetic polymorphisms do not play a role in controlling the Css of lamotrigine in treatment-resistant depressed patients treated with lamotrigine augmentation therapy.
Keyphrases